Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1000275 TORONTO, A6
Back to VTGN Full portfolio

Position in VTGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$115
-$1,097 QoQ
Shares Held
500
-76.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 48 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. VTGN ranks #391 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in VTGN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $115 500
2026-03-31 $1,212 2,127
2025-06-30 $6,594 3,297
2025-03-31 $2,277 911
2024-12-31 $5,484 1,859
2024-09-30 $13,548 4,501
2024-06-30 $3,761 1,081
2023-12-31 $7,386 1,437
2023-09-30 $14,986 2,860
2023-06-30 $278 149
2023-03-31 $1,389 11,578
2022-12-31 $2,856 28,574
2022-09-30 $355 2,371
2022-06-30 $1,844 2,097
2022-03-31 $14,783 11,922
2021-12-31 $84,978 43,579
2021-09-30 $54,421 19,862
2021-06-30 $41,377 13,136
2020-03-31 $87 200